Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
Publication year
2020Source
Frontiers in Pharmacology, 10, (2020), article 1519ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Primary and Community Care
Journal title
Frontiers in Pharmacology
Volume
vol. 10
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 5: Inflammatory diseases RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227436]
- Electronic publications [107268]
- Faculty of Medical Sciences [86157]
- Open Access publications [76396]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.